Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
Importantly, your dose may need to increase as your body adjusts and your weight loss progresses
discontinue immediately if suspected) Gallbladder disease and cholelithiasis (increased incidence with rapid weight loss) Acute kidney injury (usually secondary to severe dehydration from GI effects) Hypoglycemia (primarily when combined with insulin or sulfonylureas) Thyroid C-cell tumors (observed in rodent studies at clinically relevant exposures
GLP-1 receptor agonists, including semaglutide, have also been associated with an increased risk of gallbladder disease, including cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation)
Consider reducing or discontinuing PDE-5 inhibitor if used temporarily
Stress hits differently
